Cargando…
Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines
Many tumour cells express on their surface proteins of endogenous retroviruses (ERVs) and there are suggestions to use these retroviral antigens as target for anti-tumour vaccines. However, until now there is no convincing data showing that this strategy works, in contrast, there are considerations...
Autor principal: | Denner, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689320/ https://www.ncbi.nlm.nih.gov/pubmed/33221683 http://dx.doi.org/10.1016/j.tranon.2020.100941 |
Ejemplares similares
-
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines
por: Denner, Joachim
Publicado: (2021) -
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines
por: Bermejo, Amaia Vergara, et al.
Publicado: (2021) -
Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors
por: Kessler, Almuth Friederike, et al.
Publicado: (2014) -
Porcine Endogenous Retroviruses and Xenotransplantation, 2021
por: Denner, Joachim
Publicado: (2021) -
How Active Are Porcine Endogenous Retroviruses (PERVs)?
por: Denner, Joachim
Publicado: (2016)